Suppr超能文献

高通量膜血液透析患者中β2微球蛋白与炎症和血脂异常的关联

Association of Beta-2 Microglobulin with Inflammation and Dislipidemia in High-Flux Membrane Hemodialysis Patients.

作者信息

Topçiu-Shufta Valdete, Miftari Ramë, Haxhibeqiri Valdete, Haxhibeqiri Shpend

机构信息

Clinic of Medical Biochemistry, University Clinical Center, Pristina, Republic of Kosova; Faculty of Medicine, University of Prishtina, Republic of Kosova.

Faculty of Medicine, University of Prishtina, Republic of Kosova.

出版信息

Med Arch. 2016 Oct;70(5):348-350. doi: 10.5455/medarh.2016.70.348-350. Epub 2016 Oct 25.

Abstract

BACKGROUND

Higher than expected cardiovascular mortality in hemodialysis patients, has been attributed to dyslipidemia as well as inflammation. Beta2-Microglobulin (β2M) is an independent predictor of outcome for hemodialysis patients and a representative substance of middle molecules.

RESULTS

In 40 patients in high-flux membrane hemodialysis, we found negative correlation of β2M with high density lipoprotein (r=-0.73, p<0.001) and albumin (r= -0.53, p<0.001) and positive correlation with triglycerides (r=0.69, p<0.001), parathyroid hormone (r=0.58, p < 0.05) and phosphorus (r= 0.53, p<0.001). There was no correlation of β2M with C- reactive protein (CRP) and interleukin-6 (IL-6). During the follow-up period of three years, 6 out of 40 patients have died from cardiovascular events.

CONCLUSION

In high-flux membrane hemodialysis patients, we observed a significant relationship of β2M with dyslipidemia and mineral bone disorders, but there was no correlation with inflammation.

摘要

背景

血液透析患者心血管死亡率高于预期,这归因于血脂异常以及炎症。β2微球蛋白(β2M)是血液透析患者预后的独立预测因子,也是中分子物质的代表性物质。

结果

在40例高通量膜血液透析患者中,我们发现β2M与高密度脂蛋白呈负相关(r = -0.73,p < 0.001)以及与白蛋白呈负相关(r = -0.53,p < 0.001),与甘油三酯呈正相关(r = 0.69,p < 0.001)、与甲状旁腺激素呈正相关(r = 0.58,p < 0.05)以及与磷呈正相关(r = 0.53,p < 0.001)。β2M与C反应蛋白(CRP)和白细胞介素-6(IL-6)无相关性。在三年的随访期内,40例患者中有6例死于心血管事件。

结论

在高通量膜血液透析患者中,我们观察到β2M与血脂异常和矿物质骨代谢紊乱存在显著关系,但与炎症无相关性。

相似文献

1
Association of Beta-2 Microglobulin with Inflammation and Dislipidemia in High-Flux Membrane Hemodialysis Patients.
Med Arch. 2016 Oct;70(5):348-350. doi: 10.5455/medarh.2016.70.348-350. Epub 2016 Oct 25.
3
Rebound kinetics of beta2-microglobulin after hemodialysis.
Kidney Int. 1999 Oct;56(4):1571-7. doi: 10.1046/j.1523-1755.1999.00669.x.
6
Circulating level of alpha2-macroglobulin-beta2-microglobulin complex in hemodialysis patients.
Kidney Int. 2003 Dec;64(6):2244-52. doi: 10.1046/j.1523-1755.2003.00315.x.
8
Serum beta2-microglobulin and immunoglobulin levels in young hemodialysis patients.
Pediatr Nephrol. 1999 Feb;13(2):139-42. doi: 10.1007/s004670050582.
10
Salivary beta2-microglobulin analysis in chronic kidney disease and hemodialyzed patients.
Blood Purif. 2007;25(5-6):505-9. doi: 10.1159/000113010. Epub 2008 Jan 11.

引用本文的文献

1
Association of Beta-2 Microglobulin Concentrations with Frailty in Patients Undergoing Chronic Hemodialysis.
Int J Nephrol Renovasc Dis. 2025 Jun 10;18:151-162. doi: 10.2147/IJNRD.S513968. eCollection 2025.
4
β2-microglobulin is overexpressed in buccal cells of elderly and correlated with expression of p16 and inflammatory genes.
Saudi J Biol Sci. 2022 Oct;29(10):103418. doi: 10.1016/j.sjbs.2022.103418. Epub 2022 Aug 19.
5
Urine peptidome analysis in cardiorenal syndrome reflects molecular processes.
Sci Rep. 2021 Aug 10;11(1):16219. doi: 10.1038/s41598-021-95695-z.
6
Albuminuria and Estimated GFR as Risk Factors for Dementia in Midlife and Older Age: Findings From the ARIC Study.
Am J Kidney Dis. 2020 Dec;76(6):775-783. doi: 10.1053/j.ajkd.2020.03.015. Epub 2020 May 16.
7
Measuring serum beta2-microglobulin to predict long-term mortality in hemodialysis patients using low-flux dialyzer reuse.
Ther Clin Risk Manag. 2019 Jul 9;15:839-846. doi: 10.2147/TCRM.S210822. eCollection 2019.
8
Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases.
Front Med (Lausanne). 2017 Jun 15;4:73. doi: 10.3389/fmed.2017.00073. eCollection 2017.

本文引用的文献

1
Role of β2-microglobulin in uremic patients may be greater than originally suspected.
World J Nephrol. 2015 Feb 6;4(1):98-104. doi: 10.5527/wjn.v4.i1.98.
2
Risk factors for mortality in hemodialysis patients: two-year follow-up study.
Dis Markers. 2013;35(6):791-8. doi: 10.1155/2013/518945. Epub 2013 Nov 24.
3
Lipoprotein(a), cardiovascular disease, and contemporary management.
Mayo Clin Proc. 2013 Nov;88(11):1294-311. doi: 10.1016/j.mayocp.2013.09.003.
4
Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients.
Kidney Int. 2012 Dec;82(12):1297-303. doi: 10.1038/ki.2012.301. Epub 2012 Aug 15.
6
Dyslipidemia associated with chronic kidney disease.
Open Cardiovasc Med J. 2011;5:41-8. doi: 10.2174/1874192401105010041. Epub 2011 Feb 24.
7
Beta 2 microglobulin and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis.
Stroke. 2011 Jul;42(7):1826-33. doi: 10.1161/STROKEAHA.110.600312. Epub 2011 May 5.
9
Lipoprotein(a) as a cardiovascular risk factor: current status.
Eur Heart J. 2010 Dec;31(23):2844-53. doi: 10.1093/eurheartj/ehq386. Epub 2010 Oct 21.
10
Arterial stiffness predicts cardiovascular death independent of arterial thickness in a cohort of hemodialysis patients.
Atherosclerosis. 2010 May;210(1):145-9. doi: 10.1016/j.atherosclerosis.2009.11.013. Epub 2009 Dec 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验